rs201673771
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_001378454.1(ALMS1):c.11708G>A(p.Arg3903Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000827 in 1,614,068 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001378454.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALMS1 | NM_001378454.1 | c.11708G>A | p.Arg3903Gln | missense_variant | 18/23 | ENST00000613296.6 | NP_001365383.1 | |
ALMS1 | NM_015120.4 | c.11708G>A | p.Arg3903Gln | missense_variant | 18/23 | NP_055935.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALMS1 | ENST00000613296.6 | c.11708G>A | p.Arg3903Gln | missense_variant | 18/23 | 1 | NM_001378454.1 | ENSP00000482968.1 |
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 87AN: 152114Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000504 AC: 126AN: 250142Hom.: 0 AF XY: 0.000464 AC XY: 63AN XY: 135658
GnomAD4 exome AF: 0.000854 AC: 1248AN: 1461836Hom.: 1 Cov.: 31 AF XY: 0.000826 AC XY: 601AN XY: 727204
GnomAD4 genome AF: 0.000571 AC: 87AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 25, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 17, 2018 | The p.Arg3904Gln variant in ALMS1 is classified as likely benign due to a lack o f conservation across species, including mammals. Of note, golden hamster, mouse and rat have a glutamine (Gln) at this position. It has been identified in 119/ 126668 European chromosomes by the Genome Aggregation Database (gnomAD, http://g nomad.broadinstitute.org, dbSNP rs201673771). ACMG/AMP Criteria applied: BP4_Str ong, BS1_Supporting. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 24, 2023 | Variant summary: ALMS1 c.11705G>A (p.Arg3902Gln) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0005 in 250142 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in ALMS1 causing Alstrom Syndrome With Dilated Cardiomyopathy (0.0005 vs 0.0018), allowing no conclusion about variant significance. c.11705G>A has been reported in the literature in individuals affected/suspicion for Alstrom Syndrome (Marshall_2015) or Dilated Cardiomyopathy (Khan_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Alstrom Syndrome With Dilated Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32483926, 34935411, 25846608). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as VUS (n=3) and likely benign (n=2). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Alstrom syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 3904 of the ALMS1 protein (p.Arg3904Gln). This variant is present in population databases (rs201673771, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with ALMS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 387921). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 08, 2023 | The ALMS1 c.11708G>A; p.Arg3903Gln variant (rs201673771), also known as NM_015120.4: c.11711G>A; p.Arg3904Gln, has been reported in the literature as a variant of uncertain significance, but clinical information was not provided (Dineiro 2020). This variant is also reported in ClinVar (Variation ID: 387921). It is found in the general population with an overall allele frequency of 0.05% (146/281546 alleles) in the Genome Aggregation Database. Computational analyses predict that this variant is tolerated (REVEL: 0.092). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Dineiro M et al. Comprehensive genomic diagnosis of inherited retinal and optical nerve disorders reveals hidden syndromes and personalized therapeutic options. Acta Ophthalmol. 2020 Dec;98(8):e1034-e1048. PMID: 32483926. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2024 | Reported in a cohort with a clinical diagnosis of blindness, no additional clinical or segregation information was provided (PMID: 32483926); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32483926) - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at